02:22 PM EDT, 10/16/2025 (MT Newswires) -- Praxis Precision Medicines ( PRAX ) said two phase 3 trials of its investigational drug ulixacaltamide in essential tremor met primary and secondary endpoints.

Shares surged nearly 200% as intraday trading volume catapulted to over 11.9 million from a daily average of about 466,000.

Mira Pharmaceuticals ( MIRA ) said Thursday that new preclinical data showed oral administration of marijuana analog Mira-55 provided "superior" pain normalization and significantly reduced inflammation, outperforming injected morphine in an established animal model of inflammatory pain.

Shares surged 42% as intraday trading volume soared to over 102.5 million from a daily average of roughly 1.2 million.

Apollomics ( APLM ) said late Wednesday that it received a letter from Nasdaq stating that the company is compliant with the stock exchange's continued listing requirements.

Shares soared 45% as intraday trading volume rose to more than 216,000 from a daily average of about 53,000.

Price: 170.68, Change: +113.33, Percent Change: +197.61